Contact information
Research groups
Colleges
Angharad de Cates
BMBCh (Hons), DPhil, PGCert Higher Ed, MRCPsych, FHEA
Honorary Member
- NIHR Clinical Lecturer, Institute for Mental Health, University of Birimingham
- Honorary Consultant Psychiatrist
- Honorary Postdoctoral Clinical Researcher, University of Oxford
Until February 2024, I was clinical postdoctoral fellow funded by the Guarantors of Brain in the department, supported by Professor Catherine Harmer and Dr Susannah Murphy (DoP, Oxford), Professor Thomas Nichols and Dr Anya Topiwala (BDI, Oxford) and Professor Rachel Upthegrove (Birmingham). I also completed a DPhil (part-time) in the department between 2018 and 2022, supervised by Catherine Harmer, Phil Cowen and Susannah Murphy.
I'm now an NIHR Clinical Lecturer at the Institute for Mental Health, University of Birmingham and an honorary member of the department.
My research interests include neurocognition, self-harm and psychopharmacology across different mental illnesses - especially involving mood and psychotic disorders. I also am interested in investigating whether one group of new agents, which act as agonists at the 5HT4 receptor, may work as antidepressants and / or improve cognition in humans using behavioural tasks and brain imaging.
I am also an Honorary Consultant Psychiatrist, and Academic Lead for Equality, Diversity and Inclusion for the Oxford Health BRC.
Externally, I'm a section editor for the British Journal of Psychiatry co-leading the BJPsych Journal Clubs, and I'm a member of the Royal College of Psychiatrists Psychopharmacology Committee co-leading on their public education work.
Key publications
-
5-HT4 Receptor Agonist Effects on Functional Connectivity in the Human Brain: Implications for Procognitive Action.
Journal article
de Cates AN. et al, (2023), Biol Psychiatry Cogn Neurosci Neuroimaging, 8, 1124 - 1134
-
The Effect of the 5-HT4 Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain.
Journal article
de Cates AN. et al, (2022), Front Psychiatry, 13
-
Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task.
Journal article
de Cates AN. et al, (2021), Transl Psychiatry, 11
-
Self-harm, suicidal ideation, and the positive symptoms of psychosis: Cross-sectional and prospective data from a national household survey.
Journal article
de Cates AN. et al, (2021), Schizophr Res, 233, 80 - 88
-
Gender equality in academic publishing: action from the BJPsych.
Journal article
Upthegrove R. et al, (2020), Br J Psychiatry, 1 - 3
-
Translating the promise of 5HT4 receptor agonists for the treatment of depression.
Journal article
Murphy SE. et al, (2021), Psychol Med, 51, 1111 - 1120
Recent publications
-
The value of mental science: we publish what matters.
Journal article
Malhi GS. et al, (2025), Br J Psychiatry, 1 - 5
-
Systematic Review and Meta-Analysis: The Association Between Newer-Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder.
Journal article
Türkmen C. et al, (2025), J Am Acad Child Adolesc Psychiatry
-
TRANSLATING 5-HT4R AGONISM INTO MENTAL ILLNESS: POTENTIAL CLINICAL APPLICATIONS FOR MOOD DISORDER AND COGNITIVE IMPAIRMENT
Journal article
de Cates A. et al, (2025), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, i71 - i71
